Alzinova AB (publ) (STO: ALZ)
Sweden
· Delayed Price · Currency is SEK 3.720
-0.200 (-5.10%)
Nov 18, 2024, 5:11 PM CET
Alzinova AB Revenue
Alzinova AB had revenue of 5.77M SEK in the quarter ending September 30, 2024, with 74.88% growth. This brings the company's revenue in the last twelve months to 17.39M, up 0.01% year-over-year. In the year 2023, Alzinova AB had annual revenue of 19.87M with 19.49% growth.
Revenue (ttm)
17.39M
Revenue Growth
+0.01%
P/S Ratio
n/a
Revenue / Employee
3.48M
Employees
5
Market Cap
329.91M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 19.87M | 3.24M | 19.49% |
| Dec 31, 2022 | 16.63M | -688.74K | -3.98% |
| Dec 31, 2021 | 17.32M | 2.42M | 16.27% |
| Dec 31, 2020 | 14.90M | 8.09M | 118.80% |
| Dec 31, 2019 | 6.81M | -2.55M | -27.26% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca PLC | 519.35B |
| Swedish Orphan Biovitrum AB (publ) | 25.44B |
| Sectra AB (publ) | 3.17B |
| Getinge AB (publ) | 33.59B |
| Camurus AB (publ) | 1.69B |
| Vitrolife AB (publ) | 3.56B |
| Medicover AB (publ) | 22.60B |
| Elekta AB (publ) | 18.12B |